XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Total
Balance at Dec. 31, 2021 $ 128 $ 167,032 $ (38) $ 12,099 $ 179,221
Balance (in shares) at Dec. 31, 2021 12,804        
Increase (Decrease) in Stockholders' Equity          
Shares of common stock issued in connection with employee stock purchase plan $ 1 1,560     1,561
Shares of common stock issued in connection with employee stock purchase plan (in shares) 52        
Shares of common stock issued in connection with incentive stock plan   23     23
Shares of common stock issued in connection with incentive stock plan (in shares) 4        
Shares used to pay taxes on stock grants   (837)     (837)
Shares used to pay taxes on stock grants (in shares) (27)        
Issuance of restricted stock award and units $ 3 (3)      
Issuance of restricted stock award and units (in shares) 373        
Stock-based compensation expense   3,305     3,305
Net Income (Loss)       (3,773) (3,773)
Net unrealized gain on derivative contracts     38   38
Balance at Apr. 01, 2022 $ 132 171,080   8,326 179,538
Balance (in shares) at Apr. 01, 2022 13,206        
Balance at Dec. 31, 2021 $ 128 167,032 $ (38) 12,099 179,221
Balance (in shares) at Dec. 31, 2021 12,804        
Increase (Decrease) in Stockholders' Equity          
Net Income (Loss)         (8,099)
Balance at Jul. 01, 2022 $ 132 172,678   4,000 176,810
Balance (in shares) at Jul. 01, 2022 13,215        
Balance at Apr. 01, 2022 $ 132 171,080   8,326 179,538
Balance (in shares) at Apr. 01, 2022 13,206        
Increase (Decrease) in Stockholders' Equity          
Shares used to pay taxes on stock grants   (116)     (116)
Shares used to pay taxes on stock grants (in shares) (5)        
Issuance of restricted stock award and units (in shares) 14        
Stock-based compensation expense   1,714     1,714
Net Income (Loss)       (4,326) (4,326)
Balance at Jul. 01, 2022 $ 132 172,678   4,000 176,810
Balance (in shares) at Jul. 01, 2022 13,215        
Balance at Dec. 30, 2022 $ 133 177,718   3,651 $ 181,502
Balance (in shares) at Dec. 30, 2022 13,296       13,296
Increase (Decrease) in Stockholders' Equity          
Shares of common stock issued in connection with employee stock purchase plan $ 1 1,391     $ 1,392
Shares of common stock issued in connection with employee stock purchase plan (in shares) 92        
Shares used to pay taxes on stock grants   (124)     (124)
Shares used to pay taxes on stock grants (in shares) (7)        
Issuance of restricted stock award and units $ 1 (1)      
Issuance of restricted stock award and units (in shares) 108        
Stock-based compensation expense   1,533     1,533
Net Income (Loss)       932 932
Balance at Mar. 31, 2023 $ 135 180,517   4,583 185,235
Balance (in shares) at Mar. 31, 2023 13,489        
Balance at Dec. 30, 2022 $ 133 177,718   3,651 $ 181,502
Balance (in shares) at Dec. 30, 2022 13,296       13,296
Increase (Decrease) in Stockholders' Equity          
Net Income (Loss)         $ 1,329
Balance at Jun. 30, 2023 $ 135 181,747   4,980 $ 186,862
Balance (in shares) at Jun. 30, 2023 13,504       13,504
Balance at Mar. 31, 2023 $ 135 180,517   4,583 $ 185,235
Balance (in shares) at Mar. 31, 2023 13,489        
Increase (Decrease) in Stockholders' Equity          
Shares of common stock issued in connection with incentive stock plan   7     7
Shares of common stock issued in connection with incentive stock plan (in shares) 2        
Shares used to pay taxes on stock grants   (64)     (64)
Shares used to pay taxes on stock grants (in shares) (4)        
Issuance of restricted stock award and units (in shares) 17        
Stock-based compensation expense   1,287     1,287
Net Income (Loss)       397 397
Balance at Jun. 30, 2023 $ 135 $ 181,747   $ 4,980 $ 186,862
Balance (in shares) at Jun. 30, 2023 13,504       13,504